Table 3.
Characteristics of the 54 pediatric ALL patients
| Characteristics | Results |
|---|---|
| Male, N (%) | 34 (63.0) |
| Age, median (IQR), years | 6.5 (4.0-14.0) |
| Number of thiopurine metabolite measurements per patient, median (IQR) | 4.5 (2.0-7.0) |
| TPMT genotype, N (%) | |
| *1/*1 (normal metabolizer) | 53 (98.1) |
| *1/*3C (intermediate metabolizer) | 1 (1.9) |
| NUDT15 genotype, N (%) | |
| *1/*1 (normal metabolizer) | 43 (79.6) |
| *1/*2 (intermediate metabolizer) | 5 (9.3) |
| *1/*3 (intermediate metabolizer) | 2 (3.7) |
| *1/*5 (indeterminate phenotype) | 2 (3.7) |
| *1/*6 (indeterminate phenotype) | 2 (3.7) |